Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)
| 41.69 Delayed Data As of Oct 23 |  +0.26 / +0.63%Today’s Change | 22.00 Today|||52-Week Range 59.32 | -- Year-to-Date |
Latest ZNTL News | Press Releases
No recent news for Zentalis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 41.43 |
| Today’s open | 41.25 |
| Day’s range | 40.83 - 41.98 |
| Volume | 4,480 |
| Average volume (3 months) | 181,253 |
| Market cap | $1.7B |
Data as of 3:59pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | -116.74% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -$0.74 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$45.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
